Clovis Oncology and Foundation Medicine announce diagnostic collaboration

BOULDER - Clovis Oncology Inc. (Nasdaq: CLVS) and Foundation Medicine Inc. today announced they have entered into a collaboration aimed at developing an in-vitro diagnostic (IVD) to identify... Read More

By: Steve Monday August 6, 2012 0 comments Tags: Clovis Oncology, Foundation Medicine, Michael J. Pellini, Patrick J. Mahaffey, Rucaparib